In a bid to improve the surveillance of COVID-19 in hospitals, Thermo Fisher Scientific announced the release of its AerosolSense Bioaerosol Sampler on 24 March.
The device, roughly the size of a hotel safe, processes indoor air to detect any SARS-CoV-2 particles present. It can...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?